The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma-Reference-Cited by-同舟云学术

The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma

Published:2019-05-07 Issue:11 Volume:60 Page:2658-2668
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ferreira Germano Aguiar¹²^ORCID,Thomé Carolina Hassibe¹²^ORCID,Simão Ana Maria Sper³,Scheucher Priscila Santos¹⁴^ORCID,Silva Cleide Lúcia Araújo¹^ORCID,Chahud Fernando⁵^ORCID,Ciancaglini Pietro³^ORCID,Leopoldino Andreia Machado¹⁶^ORCID,Rego Eduardo Magalhães¹⁴^ORCID,Faça Vitor Marcel¹²^ORCID,dos Santos Guilherme Augusto¹⁷^ORCID

Affiliation:

1. Hemocenter of Ribeirão Preto, 14051-140 Ribeirão Preto, SP, Brazil;

2. Department of Biochemistry and Immunology, Ribeirão Preto Medical School - University of São Paulo, Ribeirão Preto, SP, Brazil;

3. Department of Chemistry, Faculty of Philosophy Sciences and Letters of Ribeirão Preto - University of São Paulo, Ribeirão Preto, SP, Brazil;

4. Department of Internal Medicine, Ribeirão Preto Medical School - University of São Paulo, Ribeirão Preto, SP, Brazil;

5. Department of Pathology, Ribeirão Preto Medical School - University of São Paulo, Ribeirão Preto, SP, Brazil;

6. Department of Clinical, Toxicological and Bromatological Analyzes, Faculty of Pharmaceutical Sciences of Ribeirão Preto - University of São Paulo, Ribeirão Preto, SP, Brazil;

7. Department of Medicine, University of Ribeirão Preto (UNAERP), Ribeirão Preto, SP, Brazil

Funder

FundaÃ§Ã£o de Apoio ao Ensino, Pesquisa e AssistÃªncia do Hospital das ClÃnicas da Faculdade de Medicina de RibeirÃ£o Preto da Universidade de SÃ£o Paulo

FundaÃ§Ã£o de Amparo Ã Pesquisa do Estado de SÃ£o Paulo

Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃ³gico

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1607326

Reference47 articles.

1. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma

2. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma?

3. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era